Last updated on December 2018

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)


Brief description of study

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Clinical Study Identifier: NCT01848561

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Precision Research Institute - San Diego /ID# 103638
San Diego, CA United States
3.38miles
  Connect »

ABBVIE CALL CENTER

Precision Research Institute - San Diego /ID# 113445
San Diego, CA United States
3.38miles
  Connect »

ABBVIE CALL CENTER

Southern California Res. Ctr. /ID# 116898
Coronado, American Samoa
5.43miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.